Laurion Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Laurion Capital Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-268,846	Closed	-$11.6M	–	940
2020 Q4	$11.6M	Buy	268,846 +150,381	+127%	+$7.41M	0.09%	174
2020 Q3	$6.53M	Buy	118,465 +99,527	+526%	+$6.33M	0.08%	199
2020 Q2	$1.2M	Buy	+18,938	New	+$1.3M	0.01%	386
2019 Q4	–	Sell	-41,391	Closed	-$2.01M	–	1323
2019 Q3	$2.01M	Buy	+41,391	New	+$2.16M	0.01%	493
2016 Q3	–	Sell	-105,000	Closed	-$1.74M	–	1150
2016 Q2	$1.74M	Buy	+105,000	New	+$2.12M	0.03%	411

Other funds holding GBT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Laurion Capital Management's GBT Position: Q1 2021 in Review

Laurion Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2021, closing a stake of 268,846 shares — an estimated $11.6M sold.

Laurion Capital Management first reported a position in GBT in Q2 2016 and held it in 5 quarters. The position peaked at $11.6M in Q4 2020. 214 funds tracked by Wall St. Rank hold GBT as of Q1 2021.

Laurion Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
Laurion Capital Management sold 268,846 Global Blood Therapeutics, Inc. shares in Q1 2021, an estimated $11.6M.
Laurion Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2016 and held it in 5 quarters.
Laurion Capital Management's Global Blood Therapeutics, Inc. position peaked at $11.6M in Q4 2020.
214 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2021.

Based on Laurion Capital Management's 13F filing for Q1 2021, filed 14 May 2021.